Dr. Early is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
New York State Department of Health
295 Main Street
Buffalo, NY 14203Phone+1 716-847-4300Fax+1 716-847-4328
Summary
- Dr. Amy Early is a medical oncologist based in Buffalo, NY. She completed her residency in Internal Medicine at the University at Buffalo and her fellowship in Medical Oncology at Roswell Park Comprehensive Cancer Institute, after obtaining her medical degree from Drexel University College of Medicine in 1976. She currently serves as a Medical Coordinator for the New York State Department of Health. Dr. Early has contributed to several publications, focusing on lung and breast cancer treatments, and her work has been recognized with citations by other research. Additionally, she is a Fellow of the American College of Physicians.
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 1978 - 1980- University at BuffaloResidency, Internal Medicine, 1976 - 1978
Drexel University College of MedicineClass of 1976
Certifications & Licensure
NY State Medical License 1977 - 2026
PA State Medical License 1997 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow American College of Physicians
Publications & Presentations
PubMed
- Patients' Preferences for Adjuvant Osimertinib in Non-Small-Cell Lung Cancer After Complete Surgical Resection: What Makes It Worth It to Patients?Muhammad Awidi, Angel Mier-Hicks, Stuthi Perimbeti, Kristopher Attwood, Hongbin Chen
Clinical Lung Cancer. 2024-09-01 - 7 citationsSystemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx.Shipra Gandhi, Mateusz Opyrchal, Melissa J Grimm, Ronald T Slomba, Kathleen M Kokolus
Journal for Immunotherapy of Cancer. 2023-11-01 - 3 citationsLack of racial differences in clinical outcomes of breast cancer patients receiving neoadjuvant chemotherapy: a single academic center study.Maithreyi Sarma, Stuthi Perimbeti, Samar Nasir, Kristopher Attwood, Ankita Kapoor
Breast Cancer Research and Treatment. 2022-04-01
Abstracts/Posters
- Immune Subsets by GI Tumor TypeEarly A, Pabla S, Conroy JM, Nesline MK, Glenn S, Papanicolau-Sengos A, Burgher B, Giamo V, Andreas J, DePietro P, Lenzo F,Wang Y, Morrison C, Society for Immunotherapy of Cancer 33rd Annual Meeting, Washington, DC, 11/9/2018
Lectures
- Immunotherapy and Targeted Therapy for Cancer of the Lung. City-Wide Grand RoundsJacobs Schoold of Medicine & Biomedical Sciences - 9/14/2017
- : Clinical Impact of Genomic Sequencing in Cancer of the LungLouisianna State University School of Medicine - 11/18/2016
- Early AP: Plenary Session. The Obesity Epidemic: Impact on Breast Cancer and Survivorship. National Consortium of Breast Centers Annual Interdisciplinary Breast Ce...
- Join now to see all
Professional Memberships
- Member
- Fellow
- Medical Society of the State of New YorkMember
- Medical Society of the County of ErieMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
